Drugs / Striatin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07089329 | May 2025 → Feb 2026 | protein-energy malnutrition | Universitas Sriwijaya | Completed | No outcome recorded |
| Phase 3 | NCT06558071 | Oct 2024 → May 2025 | lactation disease | Dexa Medica Group | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Striatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07089329 ↗ |
| Route | Oral | “The route of administration can be oral or via nasogastric tube.” NCT07089329 ↗ |
| Route | Other | “The route of administration can be oral or via nasogastric tube.” NCT07089329 ↗ |